erlotinib hydrochloride has been researched along with Anaphylaxis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Han, J; He, J; Huang, W; Xiong, C; Zhu, H; Zhu, Z | 1 |
1 other study(ies) available for erlotinib hydrochloride and Anaphylaxis
| Article | Year |
|---|---|
Common and uncommon adverse cutaneous reactions to erlotinib: a study of 20 Chinese patients with cancer.
Topics: Adult; Aged; Anaphylaxis; Antineoplastic Agents; Asian People; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Skin Diseases | 2018 |